Fertility Tourism - Global Strategic Business Report

The global market for Fertility Tourism was estimated at US$1.5 Billion in 2024 and is projected to reach US$5.3 Billion by 2030, growing at a CAGR of 23.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Fertility Tourism market.

Global Fertility Tourism Market - Key Trends & Drivers Summarized

Why Is Fertility Tourism Emerging as a Cross-Border Lifeline for Reproductive Hope?

Fertility tourism - also known as reproductive or cross-border reproductive care - is witnessing significant growth as individuals and couples travel abroad in pursuit of assisted reproductive technologies (ART) like IVF, egg donation, surrogacy, and sperm donation. Driven by disparities in cost, availability, legal frameworks, and success rates, this global movement is giving rise to a thriving medical tourism sub-sector that blends healthcare access with international travel. Many turn to fertility tourism due to restrictive regulations in their home countries - such as bans on commercial surrogacy, age or marital status limits, or constraints on LGBTQ+ family-building - compelling them to seek treatment in more permissive destinations. Countries like India, Ukraine, Spain, Greece, Mexico, and the United States have emerged as key hubs offering comprehensive and comparatively affordable fertility services, attracting patients from Western Europe, North America, the Middle East, and Asia. The emotional and financial stakes are high, and the ability to combine high-quality medical care with discretion, reduced waiting times, and legal protection has made fertility tourism an increasingly sought-after solution in the global reproductive health landscape.

How Are Legal and Ethical Landscapes Shaping Fertility Tourism Hotspots?

Legal frameworks and ethical considerations are central to the global fertility tourism ecosystem, often determining where patients choose to travel for treatment. Countries with liberal ART regulations - allowing procedures like anonymous egg/sperm donation, gestational surrogacy, and embryo freezing for non-medical reasons - are becoming top choices for international patients. For instance, Spain and the Czech Republic are preferred for donor egg IVF due to legal anonymity and donor availability, while Mexico and Colombia have gained traction for affordable surrogacy options and patient-friendly laws. Meanwhile, restrictive or evolving regulations in countries like Germany, France, China, and parts of the Middle East are pushing individuals to seek services abroad. Ethical concerns - especially around commercial surrogacy, exploitation, and informed consent - have prompted reforms in countries like India and Thailand, leading to the closure of some services to foreigners or the introduction of stricter oversight. These shifting legal terrains create both challenges and opportunities for fertility clinics and agencies, who must navigate compliance, cross-border legal recognition of parental rights, and the ethical treatment of surrogates and donors. Increasingly, patients are prioritizing not just affordability, but also legal clarity, medical standards, and ethical safeguards when choosing a destination for fertility care.

What Role Are Demographics, Social Norms, and Accessibility Playing in Market Expansion?

Changing social norms, demographic trends, and reproductive challenges are fueling global demand for fertility tourism. The rise in infertility rates - driven by lifestyle factors, delayed childbearing, environmental influences, and rising rates of chronic conditions - is prompting individuals to explore reproductive care across borders. Meanwhile, growing acceptance of non-traditional family structures, including same-sex couples, single parents by choice, and older individuals seeking parenthood, is widening the demand base for ART services. Many of these patient groups face legal or institutional barriers in their home countries, making fertility-friendly nations more attractive. Accessibility improvements, such as streamlined visa processes for medical tourists, multilingual fertility coordinators, and bundled treatment packages, are also removing logistical obstacles. Technological advancements in telehealth, remote consultations, and digital fertility monitoring apps are helping patients begin their journey from afar, reducing initial barriers and enhancing transparency. Furthermore, social media, online forums, and fertility influencers are increasing awareness about global options, enabling peer-to-peer learning and testimonial-driven decision-making. As reproductive aspirations increasingly transcend borders, these social and demographic shifts are establishing fertility tourism as both a personal solution and a growing global industry.

What Are the Core Growth Drivers Accelerating the Fertility Tourism Market Globally?

The growth in the Fertility Tourism market is driven by several factors rooted in medical globalization, cost differentials, demographic shifts, and legal divergence across borders. One of the primary drivers is the significant variation in treatment costs - IVF and surrogacy procedures in countries like India, Ukraine, and Georgia can be up to 70% less expensive than in the U.S. or U.K., even after accounting for travel and accommodation. At the same time, long waiting periods for ART services in public healthcare systems across countries like Canada and the U.K. are prompting patients to seek faster access abroad. The liberalization of ART laws in destination countries, alongside strategic government support for medical tourism, is also contributing to growth by improving infrastructure and international patient services. Rising infertility prevalence, particularly in urban populations, is expanding the patient pool, while technological standardization in fertility labs ensures consistent success rates across reputable international clinics. Additionally, the growing presence of fertility agencies, concierge services, and international surrogacy networks is facilitating smoother end-to-end coordination of travel, legal contracts, and post-treatment care. Finally, increased openness around reproductive challenges - supported by advocacy groups, influencers, and celebrities - has de-stigmatized ART and created a demand surge that crosses national borders, reinforcing fertility tourism's status as a vital solution in the future of reproductive healthcare.

Scope of Study:

The report analyzes the Fertility Tourism market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Treatment (Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment, Sperm Donation Treatment); Age Group (18-24, 25-34, 35-44, 45-54)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Donor Egg Treatment segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 26.5%. The IVF With Own Egg Treatment segment is also set to grow at 22.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $415.0 Million in 2024, and China, forecasted to grow at an impressive 31.2% CAGR to reach $1.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Fertility Tourism Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Fertility Tourism Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Fertility Tourism Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Bangkok Hospital, Barbados Fertility Centre, BioTexCom Center for Human Reproduction, Bourn Hall Clinic, Clinica Tambre and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Fertility Tourism market report include:

• Bangkok Hospital
• Barbados Fertility Centre
• BioTexCom Center for Human Reproduction
• Bourn Hall Clinic
• Clinica Tambre
• Copenhagen Fertility Center
• Dunya IVF Clinic
• Embryolab Fertility Clinic
• Fertility Associates
• Fertility Center Mexico
• Fertility First
• GREFI (Grupo de Fertilidad y Ginecología)
• IVI Fertility
• Life Clinic Athens
• Medfem Fertility Clinic
• NewLife IVF
• North Cyprus IVF Centre
• Nova IVF Fertility
• Reprofit International
• Sanatorium HELIOS

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.